March 16, 2011 (CHAPEL HILL, NC)—Research Triangle, NC research and consulting firm Thought Leader Select has initiated a new assessment of medical experts in the field of oncology for the biopharmaceutical industry.
A Canadian subsidiary of a top 10 global biopharmaceutical company has hired the firm to study the skills and experiences of 40 key opinion leaders in the treatment of lung cancer. Thought Leader Select is offering the client company an objective, systematic foundational approach to selecting physicians and other health care professionals within the Canadian care environment to assist the company during its stretch-run of activities in support of the new cancer treatment’s development.
The selected key opinion leaders in Canadian oncology circles will provide a variety of services to the company, including advisory board participation, conducting clinical studies, and offering one-on-one consultations with the company’s scientific and medical teams. Thought Leader Select’s methodology, while compliant with Office of Inspector General guidelines in the United States, is also compliant with Canadian regulations such as the Personal Information Protection and Electronic Documents Act (PIPEDA).
“We have been privileged to work with this company on multiple projects in several therapeutic areas, to ensure that its new product teams are positioned for success by working with the right thought leaders for the right reasons,” stated Neil Mellor, Thought Leader Select’s business development consultant. “This client has hired us to assess the skills and experiences of hundreds of thought leaders, identify and assess dozens of medical centers of excellence that are aligned with the company’s treatment areas, as well as link them with experts in the field of market access and reimbursement. This comprehensive strategy, coupled with the versatility of our methodology, will form a firm foundation for their brands—a foundation based on objectivity, transparency, and ethics.”
About Thought Leader Select
Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as “thought leaders” and “key opinion leaders”) within a host of therapeutic areas such as diabetes, oncology, and neurology.
Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.Media Contact: Brian Castle Director of Global Marketing and Client Relations 919-360-9690 email@example.com